Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;14(2):202–209. doi: 10.1111/j.1750-3639.2004.tb00054.x

Biomarkers of Proteolytic Damage Following Traumatic Brain Injury

Jose A Pineda 1,3,✉, Kevin K W Wang 1,2,4, Ronald L Hayes 1,2,4
PMCID: PMC8095934  PMID: 15193033

Abstract

The history of numerous failed clinical trials designed to identify therapeutic agents to assist in improving outcomes after traumatic brain injury points to the critical importance of understanding biochemical markers of injury. Such biomarkers should be readily accessible, provide information specific to the pathologic disruptions occurring in the central nervous system, and allow improved monitoring of the progression of secondary damage. Additionally, these biomarkers should may provide investigators a window on the individual patient's response to treatment, and should contribute to prediction of outcome. Most research on this topic to date has focused on neuron‐specific enolase (NSE) and S‐100 proteins but these have not proven to be satisfactory for a variety of reasons. A different approach is provided by the study of 2 important proteases, caspase‐3 and calpain. This paper reports the current state of knowledge concerning caspase and calpain as specific markers of TBI, and discusses alll‐spectrin, a principal substrate for both caspase and calpain, as well as initial findings regarding neurofilament 68 protein (NF‐68).

Full Text

The Full Text of this article is available as a PDF (199.1 KB).

REFERENCES

  • 1. (1999) Consensus conference Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilitation of Persons With Traumatic Brain Injury. Jama 282:974–983. [PubMed] [Google Scholar]
  • 2. (2000) TBI State Demonstration Grants . J Head Trauma Rehabil 15:750–760. [DOI] [PubMed] [Google Scholar]
  • 3. Alexander MP (1995) Mild traumatic brain injury: pathophysiology, natural history, and clinical management. Neurology 45:1253–1260. [DOI] [PubMed] [Google Scholar]
  • 4. Anderson RE HL, Nilsson O, Dijlai‐Merzoug R, Settergen G (2001) High serum S 100B levels for trauma patients without head injuries. Neurosurgery 49:1272–1273. [DOI] [PubMed] [Google Scholar]
  • 5. Astudillo R, Van der Linden J, Radegran K, Hansson LO, Aberg B (1996) Elevated serum levels of S‐100 after deep hypothermic arrest correlate with duration of circulatory arrest. Eur J Cardiothorac Surg 10:1107–1112+ADs‐ discussion 1113. [DOI] [PubMed] [Google Scholar]
  • 6. Bartus RT, Elliott PJ, Hayward NJ, Dean RL, Harbeson S, Straub JA, Li Z, Powers JC (1995) Calpain as a novel target for treating acute neurodegenerative disorders. Neurol Res 17:249–258. [DOI] [PubMed] [Google Scholar]
  • 7. Bartus RT, Hayward NJ, Elliott PJ, Sawyer SD, Baker KL, Dean RL, Akiyama A, Straub JA, Harbeson SL, Li Z (1994) Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra‐arterial administration. Stroke 25:2265–2270. [DOI] [PubMed] [Google Scholar]
  • 8. Beer R, Franz G, Srinivasan A, Hayes RL, Pike BR, Newcomb JK, Zhao X, Schmutzhard E, Poewe W, Kampfl A (2000) Temporal profile and cell subtype distribution of activated caspase‐3 following experimental traumatic brain injury. J Neurochem 75:1264–1273. [DOI] [PubMed] [Google Scholar]
  • 9. Behrens MM, Martinez JL, Moratilla C, Renart J (1995) Apoptosis induced by protein kinase C inhibition in a neuroblastoma cell line. Cell Growth Differ 6:1375–1380. [PubMed] [Google Scholar]
  • 10. Bellamy R (1984) The causes of death in conventional land warfates: implications for combat casualty research. Military Medicine 149:55–62. [PubMed] [Google Scholar]
  • 11. Bernath ED, Durham R, Duddy S, Wang KKW (In Preparation) Spontaneous cytoskeletal protein proteolysis in aged Wistar rat brains.
  • 12. Bertrand R, Solary E, O'Connor P, Kohn KW, Pommier Y (1994) Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 211:314–321. [DOI] [PubMed] [Google Scholar]
  • 13. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N‐methyl‐D‐aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A 92:7162–7166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Buki A, Okonkwo DO, Wang KK, Povlishock JT (2000) Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 20:2825–2834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Chang LK, Putcha GV, Deshmukh M, Johnson EM (2002) Mitochondrial involvement in the point of no return in neuronal apoptosis. Biochimie 84:223–231. [DOI] [PubMed] [Google Scholar]
  • 16. Choi DW (1996) Ischemia‐induced neuronal apoptosis. Curr Opin Neurobiol 6:667–672. [DOI] [PubMed] [Google Scholar]
  • 17. Choi SC Bullock R (2001) Design and statistical issues in multicenter trials of severe head injury. Neurol Res 23:190–192. [DOI] [PubMed] [Google Scholar]
  • 18. Clark RS, Kochanek PM, Adelson PD, Bell MJ, Carcillo JA, Chen M, Wisniewski SR, Janesko K, Whalen MJ, Graham SH (2000) Increases in bcl‐2 protein in cerebrospinal fluid and evidence for programmed cell death in infants and children after severe traumatic brain injury. J Pediatr 137:197–204. [DOI] [PubMed] [Google Scholar]
  • 19. Clark RS, Kochanek PM, Chen M, Watkins SC, Marion DW, Chen J, Hamilton RL, Loeffert JE, Graham SH (1999) Increases in Bcl‐2 and cleavage of caspase‐1 and caspase‐3 in human brain after head injury. Faseb J 13:813–821. [DOI] [PubMed] [Google Scholar]
  • 20. Clark RS, Kochanek PM, Watkins SC, Chen M, Dixon CE, Seidberg NA, Melick J, Loeffert JE, Nathaniel PD, Jin KL, Graham SH (2000) Caspase‐3 mediated neuronal death after traumatic brain injury in rats. J Neurochem 74:740–753. [DOI] [PubMed] [Google Scholar]
  • 21. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326:1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Colicos MA, Dash PK (1996) Apoptotic morphology of dentate gyrus granule cells following experimental cortical impact injury in rats: possible role in spatial memory deficits. Brain Res 739:120–131. [DOI] [PubMed] [Google Scholar]
  • 23. Conti AC, Raghupathi R, Trojanowski JQ, McIntosh TK (1998) Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post‐traumatic period. J Neurosci 18:5663–5672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Cooper E (1994) Neuron‐specific enolase. Int J Biol Markers 4:205–210. [DOI] [PubMed] [Google Scholar]
  • 25. Copin JC, Li Y, Reola L, Chan PH (1998) Trolox and 6,7‐dinitroquinoxaline‐2,3‐dione prevent necrosis but not apoptosis in cultured neurons subjected to oxygen deprivation. Brain Res 784:25–36. [DOI] [PubMed] [Google Scholar]
  • 26. Cunningham RT, Watt M, Winder J, McKinstry S, Lawson JT, Johnston CF, Hawkins SA, Buchanan KD (1996) Serum neurone‐specific enolase as an indicator of stroke volume. Eur J Clin Invest 26:298–303. [DOI] [PubMed] [Google Scholar]
  • 27. Cunningham RT, Young IS, Winder J, O'Kane MJ, McKinstry S, Johnston CF, Dolan OM, Hawkins SA, Buchanan KD (1991) Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 21:497–500. [DOI] [PubMed] [Google Scholar]
  • 28. Dauberschmidt R, Zinsmeyer J, Mrochen H, Meyer M (1991) Changes of neuron‐specific enolase concentration in plasma after cardiac arrest and resuscitation. Mol Chem Neuropathol 14:237–245. [DOI] [PubMed] [Google Scholar]
  • 29. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391–397. [DOI] [PubMed] [Google Scholar]
  • 30. Donato R (1999) Functional roles of S 100 proteins, calcium‐binding proteins of the EF‐hand type. Biochim Biophys Acta 1450:191–231. [DOI] [PubMed] [Google Scholar]
  • 31. Egon MR, Doppenberg SCC, Bullock R (1997) Clinical trials in TBI, what can we learn from previous studies. Ann NY Acad Sci 825:305–322. [DOI] [PubMed] [Google Scholar]
  • 32. Eldadah BA, Yakovlev AG, Faden AI (1997) The role of CED‐3‐related cysteine proteases in apoptosis of cerebellar granule cells. J Neurosci 17:6105–6113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Ellis EF, McKinney JS, Willoughby KA, Liang S, Povlishock JT (1995) A new model for rapid stretch‐induced injury of cells in culture: characterization of the model using astrocytes. J Neurotrauma 12:325–339. [DOI] [PubMed] [Google Scholar]
  • 34. Fischer I, Romano‐Clarke G, Grynspan F (1991) Calpain‐mediated proteolysis of microtubule associated proteins MAP 1B and MAP2 in developing brain. Neurochem Res 16:891–898. [DOI] [PubMed] [Google Scholar]
  • 35. Flint JP, Pike BR, Hayes RL, Moffett JR, Dave JR, Lu X.‐CM, and Tortella F (2002. In Press) Accumulation of calpain and caspase‐3 cleaved alpha‐II spectrin breakdown products in CSF after middle cerebral artery occulsion in rats. J Neurotrauma (in press). [Google Scholar]
  • 36. Fraser A, Evan G (1996) A license to kill. Cell 85:781–784. [DOI] [PubMed] [Google Scholar]
  • 37. Goodman SR, Zimmer WE, Clark MB, Zagon IS, Barker JE, Bloom ML (1995) Brain spectrin: of mice and men. Brain Res Bull 36:593–606. [DOI] [PubMed] [Google Scholar]
  • 38. Gottron FJ, Ying HS, Choi DW (1997) Caspase inhibition selectively reduces the apoptotic component of oxygen‐glucose deprivation‐induced cortical neuronal cell death. Mol Cell Neurosci 9:159–169. [DOI] [PubMed] [Google Scholar]
  • 39. Gwag BJ, Lobner D, Koh JY, Wie MB, Choi DW (1995) Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen‐glucose deprivation in vitro. Neuroscience 68:615–619. [DOI] [PubMed] [Google Scholar]
  • 40. Haimoto H, Hosoda S, Kato K (1987) Differential distribution of immunoreactive S100‐alpha and S100‐beta proteins in normal nonnervous human tissues. Lab Invest 57:489–498. [PubMed] [Google Scholar]
  • 41. Hill MD, Jackowski G, Bayer N, Lawrence M, Jaeschke R (2000) Biochemical markers in acute ischemic stroke. Cmaj 162:1139–1140. [PMC free article] [PubMed] [Google Scholar]
  • 42. Horn M, Seger F, Schlote W (1995) Neuronspecific enolase in gerbil brain and serum after transient cerebral ischemia. Stroke 26:290–296+ADs‐ discussion 296–297. [DOI] [PubMed] [Google Scholar]
  • 43. Ingebrigtsen T, Romner B (2002) Biochemical Serum Markers of TBI. The Journal of Trauma Injury, Infection, and Critical Care, 52, 798–808. [DOI] [PubMed] [Google Scholar]
  • 44. Ingebrigtsen T Romner B, Trumpy JH (1997) Management of minor head injury: the value of early CT and serum protein S‐100 measurements. J Clin Neurosci 4:29–33. [DOI] [PubMed] [Google Scholar]
  • 45. Irazuzta JE, de Courten‐Myers G, Zemlan FP, Bekkedal MY, Rossi J, 3rd (2001) Serum cleaved Tau protein and neurobehavioral battery of tests as markers of brain injury in experimental bacterial meningitis. Brain Res 913:95–105. [DOI] [PubMed] [Google Scholar]
  • 46. Jacobs A, Put E, Ingels M, Put T, Bossuyt A (1996) One‐year follow‐up of technetium‐99m‐HMPAO SPECT in mild head injury. J Nucl Med 37: 1605–1609. [PubMed] [Google Scholar]
  • 47. Jenkins LW, Moszynski K, Lyeth BG, Lewelt W, DeWitt DS, Allen A, Dixon CE, Povlishock JT, Majewski TJ, Clifton GL, Young HF, Becker DP, Hayes RL (1989) Increased vulnerability of the mildly traumatized rat brain to cerebral ischemia: the use of controlled secondary ischemia as a research tool to identify common or different mechanisms contributing to mechanical and ischemic brain injury. Brain Res 477:211–224. [DOI] [PubMed] [Google Scholar]
  • 48. Johnson EM, Jr. , Greenlund LJ, Akins PT, Hsu CY (1995) Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury. J Neurotrauma 12:843–852. [DOI] [PubMed] [Google Scholar]
  • 49. Johnsson P (1996) Markers of cerebral ischemia after cardiac surgery. J Cardiothorac Vasc Anesth 10:120–126. [DOI] [PubMed] [Google Scholar]
  • 50. Jonas S, Aiyagari V, Vieira D, Figueroa M (2001) The failure of neuronal protective agents versus the success of thrombolysis in the treatment of ischemic stroke. The predictive value of animal models. Ann N Y Acad Sci 939:257–267. [DOI] [PubMed] [Google Scholar]
  • 51. Jonsson H, Johnsson P, Hoglund P, Alling C, Blomquist S (2000) Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth 14:698–701. [DOI] [PubMed] [Google Scholar]
  • 52. Jordan J, Galindo MF, Miller RJ (1997) Role of calpain‐ and interleukin‐1 beta converting enzyme‐like proteases in the beta‐amyloid‐induced death of rat hippocampal neurons in culture. J Neurochem 68:1612–1621. [DOI] [PubMed] [Google Scholar]
  • 53. Kaku Y, Yonekawa Y, Tsukahara T, Ogata N, Kimura T, Taniguchi T (1993) Alterations of a 200 kDa neurofilament in the rat hippocampus after forebrain ischemia. J Cereb Blood Flow Metab 13:402–408. [DOI] [PubMed] [Google Scholar]
  • 54. Kampfl A, Posmantur R, Nixon R, Grynspan F, Zhao X, Liu SJ, Newcomb JK, Clifton GL, Hayes RL (1996) Mu‐calpain activation and calpain‐mediated cytoskeletal proteolysis following traumatic brain injury. J Neurochem 67:1575–1583. [DOI] [PubMed] [Google Scholar]
  • 55. Kampfl A, Posmantur RM, Zhao X, Schmut‐zhard E, Clifton GL, Hayes RL (1997) Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. J Neurotrauma 14:121–134. [DOI] [PubMed] [Google Scholar]
  • 56. Kampfl A, Whitson JS, Zhao X, Posmantur R, Clifton GL, Hayes RL (1995) Calpain inhibitors reduce depolarization induced loss of tau protein in primary septo‐hippocampal cultures. Neurosci Lett 194:149–152. [DOI] [PubMed] [Google Scholar]
  • 57. Kampfl A, Zhao X, Whitson JS, Posmantur R, Dixon CE, Yang K, Clifton GL, Hayes RL (1996) Calpain inhibitors protect against depolarization‐induced neurofilament protein loss of septo‐hippocampal neurons in culture. Eur J Neurosci 8:344–352. [DOI] [PubMed] [Google Scholar]
  • 58. Kant R, Smith‐Seemiller L, Isaac G, Duffy J (1997) Tc‐HMPAO SPECT in persistent post‐concussion syndrome after mild head injury: comparison with MRI/CT. Brain Inj 11:115–124. [DOI] [PubMed] [Google Scholar]
  • 59. Kaya SS, Mahmood A, Li Y, Yavuz E, Goksel M, Chopp M (1999) Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain. Brain Res 818:23–33. [DOI] [PubMed] [Google Scholar]
  • 60. Kesler SR, Adams HF, Bigler ED (2000) SPECT, MR and quantitative MR imaging: correlates with neuropsychological and psychological outcome in traumatic brain injury. Brain Inj 14:851–857. [DOI] [PubMed] [Google Scholar]
  • 61. Kochanek PM, Clark RS, Ruppel RA, Dixon CE (2001) Cerebral resuscitation after traumatic brain injury and cardiopulmonary arrest in infants and children in the new millennium. Pediatr Clin North Am 48:661–681. [DOI] [PubMed] [Google Scholar]
  • 62. Lammie GA, Piper IR, Thomson D, Brannan F (1999) Neuropathologic characterization of a rodent model of closed head injury‐addition of clinically relevant secondary insults does not significantly potentiate brain damage. J Neurotrauma 16:603–615. [DOI] [PubMed] [Google Scholar]
  • 63. Laskowitz DT, Grocott HP, Hsia A, Copeland KR (1998) Serum Markers of Cerebral Ischemia. J Stroke Cerebro Dis 7:234–241. [DOI] [PubMed] [Google Scholar]
  • 64. Levi L, Guilburd JN, Lemberger A, Soustiel JF, Feinsod M (1990) Diffuse axonal injury: analysis of 100 patients with radiological signs. Neurosurgery 27:429–432. [PubMed] [Google Scholar]
  • 65. Leviton A, Dammann O (2002) Brain damage markers in children. Neurobiological and clinical aspects. Acta Paediatr 91:9–13. [DOI] [PubMed] [Google Scholar]
  • 66. Lyeth BG, Jenkins LW, Hamm RJ, Dixon CE, Phillips LL, Clifton GL, Young HF, Hayes RL (1990) Prolonged memory impairment in the absence of hippocampal cell death following traumatic brain injury in the rat. Brain Res 526:249–258. [DOI] [PubMed] [Google Scholar]
  • 67. Martens P (1996) Serum neuron‐specific enolase as a prognostic marker for irreversible brain damage in comatose cardiac arrest surviviors. Acad Emerg Med 3:126–131. [DOI] [PubMed] [Google Scholar]
  • 68. Martens P, Raabe A, Johnsson P (1998) Serum S‐100 and neuron‐specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 29:2363–2366. [DOI] [PubMed] [Google Scholar]
  • 69. Martin SJ, O'Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, Saido TC, Green DR (1995) Proteolysis of fodrin (non‐erythroid spectrin) during apoptosis. J Biol Chem 270:6425–6428. [DOI] [PubMed] [Google Scholar]
  • 70. Missler U, Wiesmann M, Friedrich C, Kaps M (1997) S‐100 protein and neuron‐specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28: 1956–1960. [DOI] [PubMed] [Google Scholar]
  • 71. Missler U, Wiesmann M, Wittmann G, Magerkurth O, Hagenstrom H (1999) Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin Chem 45:138–141. [PubMed] [Google Scholar]
  • 72. Mitchener A, Wyper DJ, Patterson J, Hadley DM, Wilson JT, Scott LC, Jones M, Teasdale GM (1997) SPECT, CT, and MRI in head injury: acute abnormalities followed up at six months. J Neurol Neurosurg Psychiatry 62:633–636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J (1993) Induction of apoptosis in fibroblasts by IL‐1 beta‐converting enzyme, a mammalian homolog of the C. elegans cell death gene ced‐3. Cell 75:653–660. [DOI] [PubMed] [Google Scholar]
  • 74. Moore B (1965) A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 19:739–744. [DOI] [PubMed] [Google Scholar]
  • 75. Morioka M, Fukunaga K, Yasugawa S, Nagahiro S, Ushio Y, Miyamoto E (1992) Regional and temporal alterations in Ca2+‐/calmodulin‐dependent protein kinase II and calcineurin in the hippocampus of rat brain after transient forebrain ischemia. J Neurochem 58:1798–1809. [DOI] [PubMed] [Google Scholar]
  • 76. Narayan RK, Michel ME, Ansell B, Baethmann A, Biegon A, Bracken MB, Bullock MR, Choi SC, Clifton GL, Contant CF, Coplin WM et al (2002) Clinical trials in head injury. J Neurotrauma 19:503–557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Nath R, Raser KJ, McGinnis K, Nadimpalli R, Stafford D, Wang KK (1996) Effects of ICE‐like protease and calpain inhibitors on neuronal apoptosis. Neuroreport 8:249–255. [DOI] [PubMed] [Google Scholar]
  • 78. Nath R, Raser KJ, Stafford D, Hajimohammadreza I, Posner A, Allen H, Talanian RV, Yuen P, Gilbertsen RB, Wang KK (1996) Non‐erythroid alpha‐spectrin breakdown by calpain and interleukin 1 beta‐converting‐enzyme‐like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem J 319:683–690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Neumar RW, Meng FH, Mills AM, Xu YA, Zhang C, Welsh FA, Siman R (2001) Calpain activity in the rat brain after transient forebrain ischemia. Exp Neurol 170:27–35. [DOI] [PubMed] [Google Scholar]
  • 80. Newcomb JK, Kampfl A, Posmantur RM, Zhao X, Pike BR, Liu SJ, Clifton GL, Hayes RL (1997) Immunohistochemical study of calpain‐mediated breakdown products to alpha‐spectrin following controlled cortical impact injury in the rat. J Neurotrauma 14:369–83. [DOI] [PubMed] [Google Scholar]
  • 81. Newcomb JK, Zhao X, Pike BR, Hayes RL (1999) Temporal profile of apoptotic‐like changes in neurons and astrocytes following controlled cortical impact injury in the rat. Exp Neurol 158: 76–88. [DOI] [PubMed] [Google Scholar]
  • 82. NIH (1998) Rehabilitation of persons with traumatic brain injury. NIH Consensus Statement 16:1–41. [PubMed] [Google Scholar]
  • 83. Nishida A, Emoto K, Shimizu M, Uozumi T, Yamawaki S (1994) Brain ischemia decreases phosphatidylcholine‐phospholipase D but not phosphatidylinositol‐phospholipase C in rats. Stroke 25:1247–1251. [DOI] [PubMed] [Google Scholar]
  • 84. Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, Shibanai K, Kominami E, Uchiyama Y (1995) Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 15:1001–1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Nygaard O, Langbakk B, Romner B (1998) Neuron‐specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder. Scand J Clin Lab Invest 58:183–186. [DOI] [PubMed] [Google Scholar]
  • 86. Ogata N, Yonekawa Y, Taki W, Kannagi R, Mura‐chi T, Hamakubo T, Kikuchi H (1989) Degradation of neurofilament protein in cerebral ischemia. J Neurosurg 70:103–107. [DOI] [PubMed] [Google Scholar]
  • 87. Paterakis K, Karantanas AH, Komnos A, Volikas Z (2000) Outcome of patients with diffuse axonal injury: the significance and prognostic value of MRI in the acute phase. J Trauma 49:1071–1075. [DOI] [PubMed] [Google Scholar]
  • 88. Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V (2001) Temporal profile of serum antiinflammatory and pro‐inflammatory interleukins in acute ischemic stroke patients. Neurol Sci 22:289–296. [DOI] [PubMed] [Google Scholar]
  • 89. Pike BR, Flint J, Dutta S, Johnson E, Wang KK, Hayes RL (2001) Accumulation of non‐erythroid alpha II‐spectrin and calpain‐cleaved alpha II‐spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J Neurochem 78:1297–1306. [DOI] [PubMed] [Google Scholar]
  • 90. Pike BR, Zhao X, Newcomb JK, Glenn CC, Anderson DK, Hayes RL (2000) Stretch injury causes calpain and caspase‐3 activation and necrotic and apoptotic cell death in septo‐hippocampal cell cultures. J Neurotrauma 17:283–298. [DOI] [PubMed] [Google Scholar]
  • 91. Pike BR, Zhao X, Newcomb JK, Posmantur RM, Wang KK, Hayes RL (1998) Regional calpain and caspase‐3 proteolysis of alpha‐spectrin after traumatic brain injury. Neuroreport 9:2437–2442. [DOI] [PubMed] [Google Scholar]
  • 92. Pike BR, Zhao X, Newcomb JK, Wang KK, Posmantur RM, Hayes RL (1998) Temporal relationships between de novo protein synthesis, calpain and caspase 3‐like protease activation, and DNA fragmentation during apoptosis in septo‐hippocampal cultures. J Neurosci Res 52:505–520. [DOI] [PubMed] [Google Scholar]
  • 93. Posmantur R, Hayes RL, Dixon CE, Taft WC (1994) Neurofilament 68 and neurofilament 200 protein levels decrease after traumatic brain injury. J Neurotrauma 11:533–545. [DOI] [PubMed] [Google Scholar]
  • 94. Posmantur R, Kampfl A, Siman R, Liu J, Zhao X, Clifton GL, Hayes RL (1997) A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 77:875–888. [DOI] [PubMed] [Google Scholar]
  • 95. Posmantur RM, Newcomb JK, Kampfl A, Hayes RL (2000) Light and confocal microscopic studies of evolutionary changes in neurofilament proteins following cortical impact injury in the rat. Exp Neurol 161:15–26. [DOI] [PubMed] [Google Scholar]
  • 96. Posmantur RM, Zhao X, Kampfl A, Clifton GL, Hayes RL (1998) Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats. Neurochem Res 23:1265–1276. [DOI] [PubMed] [Google Scholar]
  • 97. Raabe A, Grolms C, Keller M, Dohnert J, Sorge O, Seifert V (1998) Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien) 140:787–791+ADs‐ discussion 791–792. [DOI] [PubMed] [Google Scholar]
  • 98. Raabe A, Grolms C, Seifert V (1999) Serum markers of brain damage and outcome prediction in patients after severe head injury. Br J Neurosurg 13:56–59. [DOI] [PubMed] [Google Scholar]
  • 99. Raabe A, Menon DK, Gupta S, Czosnyka M, Pickard JD (1998) Jugular venous and arterial concentrations of serum S‐100B protein in patients with severe head injury: a pilot study. J Neurol Neurosurg Psychiatry 65:930–932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Raghupathi R, Conti AC, Graham DI, Kra‐jewski S, Reed JC, Grady MS, Trojanowski JQ, McIntosh TK (2002) Mild traumatic brain injury induces apoptotic cell death in the cortex that is preceded by decreases in cellular Bcl‐2 immunoreactivity. Neuroscience 110:605–616. [DOI] [PubMed] [Google Scholar]
  • 101. Raghupathi R, Margulies SS (2002) Traumatic axonal injury after closed head injury in the neonatal pig. J Neurotrauma 19:843–853. [DOI] [PubMed] [Google Scholar]
  • 102. Riederer BM, Zagon IS, Goodman SR (1987) Brain spectrin(240/235) and brain spectrin(240/235E): differential expression during mouse brain development. J Neurosci 7:864–874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Ringger NC, Silver X, O'Steen B, Brabham JG, Deford SM, Pike BR, Pineda J, Hayes RL (In Preparation) CSF Calpain‐induced spectrin breakdown products predict injury magnitude and chronic lesion sized in a rat model of TBI.
  • 104. Ringleb PA, Schellinger PD, Schranz C, Hacke W (2002) Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful. Stroke 33:1437–1441. [DOI] [PubMed] [Google Scholar]
  • 105. Rink A, Fung KM, Trojanowski JQ, Lee VM, Neugebauer E, McIntosh TK (1995) Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol 147:1575–1583. [PMC free article] [PubMed] [Google Scholar]
  • 106. Roine R O, Somer H, Kaste M, Viinikka L, Karonen S L (1989) Neurological outcome after out‐of‐hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch Neurol 46:753–756. [DOI] [PubMed] [Google Scholar]
  • 107. Romner B, Ingebrigtsen T, Kongstad P, Borgesen SE (2000) Traumatic brain damage: serum S‐100 protein measurements related to neuroradiological findings. J Neurotrauma 17: 641–647. [DOI] [PubMed] [Google Scholar]
  • 108. Ross SA, Cunningham RT, Johnston CF, Rowlands BJ (1996) Neuron‐specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg 10:471–476. [DOI] [PubMed] [Google Scholar]
  • 109. Saatman KE, Bozyczko‐Coyne D, Marcy V, Siman R, McIntosh TK (1996) Prolonged calpain‐mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J Neuropathol Exp Neurol 55:850–860. [DOI] [PubMed] [Google Scholar]
  • 110. Saido TC, Sorimachi H, Suzuki K (1994) Calpain: new perspectives in molecular diversity and physiological‐pathological involvement. Faseb J 8:814–822. [PubMed] [Google Scholar]
  • 111. Scheidler MG, Shultz BL, Schall L, Ford HR (2000) Risk factors and predictors of mortality in children after ejection from motor vehicle crashes. J Trauma 49:864–868. [DOI] [PubMed] [Google Scholar]
  • 112. Schwartz SM, Duffy JY, Pearl JM, Nelson DP (2001) Cellular and molecular aspects of myocardial dysfunction. Crit Care Med 29:S214–219. [DOI] [PubMed] [Google Scholar]
  • 113. Sellman M, Ivert T, Ronquist G, Caesarini K, Persson L, Semb BK (1992) Central nervous system damage during cardiac surgery assessed by 3 different biochemical markers in cerebrospinal fluid. ScandJ Thorac Cardiovasc Surg 26:39–45. [DOI] [PubMed] [Google Scholar]
  • 114. Shaw GJ, Jauch EC, Zemlan FP (2002) Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann Emerg Med 39:254–257. [DOI] [PubMed] [Google Scholar]
  • 115. Singhal A, Baker AJ, Hare GM, Reinders FX, Schlichter LC, Moulton RJ (2002) Association between Cerebrospinal Fluid Interleukin‐6 Concentrations and Outcome after Severe Human Traumatic Brain Injury. J Neurotrauma 19:929–937. [DOI] [PubMed] [Google Scholar]
  • 116. Sloviter RS (1996) Hippocampal pathology and pathophysiology in temporal lobe epilepsy. Neurologia 11 Suppl 4:29–32. [PubMed] [Google Scholar]
  • 117. Squier MK, Miller AC, Malkinson AM, Cohen JJ (1994) Calpain activation in apoptosis. J Cell Physiol 159:229–237. [DOI] [PubMed] [Google Scholar]
  • 118. Suzuki K, Sorimachi H, Yoshizawa T, Kinbara K, Ishiura S (1995) Calpain: novel family members, activation, and physiologic function. Biol Chem Hoppe Seyler 376:523–529. [DOI] [PubMed] [Google Scholar]
  • 119. Thomaidou D, Mione MC, Cavanagh JF, Parnavelas JG (1997) Apoptosis and its relation to the cell cycle in the developing cerebral cortex. J Neurosci 17:1075–1085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120. Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E (1989) S‐100ao protein in blood and urine during open‐heart surgery. Clin Chem 35: 1942–1944. [PubMed] [Google Scholar]
  • 121. van Engelen BG, Lamers KJ, Gabreels FJ, Wevers RA, van Geel WJ, Borm GF (1992) Age‐related changes of neuron‐specific enolase, S‐100 protein, and myelin basic protein concentrations in cerebrospinal fluid. Clin Chem 38:813–816. [PubMed] [Google Scholar]
  • 122. Vanags DM, Porn‐Ares MI, Coppola S, Burgess DH, Orrenius S (1996) Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 271:31075–31085. [DOI] [PubMed] [Google Scholar]
  • 123. Villa PG, Henzel WJ, Sensenbrenner M, Henderson CE, Pettmann B (1998) Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J Cell Sci 111:713–722. [DOI] [PubMed] [Google Scholar]
  • 124. Wang KK (2000) Calpain and caspase: can you tell the difference. Trends Neurosci 23:20–26. [DOI] [PubMed] [Google Scholar]
  • 125. Wang KK, Posmantur R, Nath R, McGinnis K, Whitton M, Talanian RV, Glantz SB, Morrow JS (1998) Simultaneous degradation of alphall‐and betall‐spectrin by caspase 3 (CPP32) in apoptotic cells. J Biol Chem 273:22490–22497. [DOI] [PubMed] [Google Scholar]
  • 126. Wang KK, Villalobo A, Roufogalis BD (1989) Calmodulin‐binding proteins as calpain substrates. Biochem J 262:693–706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127. Wang KK, Yuen PW (1994) Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol Sci 15:412–419. [DOI] [PubMed] [Google Scholar]
  • 128. Westaby S, Johnsson P, Parry AJ, Blomqvist S, Solem JO, Alling C, Pillai R, Taggart DP, Grebenik C, Stahl E (1996) Serum S 100 protein: a potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg 61:88–92. [DOI] [PubMed] [Google Scholar]
  • 129. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A (1997) Comparison of serial S‐100 and NSE serum measurements after severe head injury. Acta Neurochir (Wien) 139:1161–1164+ADs‐ discussion 1165. [DOI] [PubMed] [Google Scholar]
  • 130. Woertgen C, Rothoerl RD, Metz C, Brawanski A (1999) Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma 47:1126–1130. [DOI] [PubMed] [Google Scholar]
  • 131. Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AI (1997) Activation of CPP32‐like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 17:7415–7424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132. Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T (1995) Diagnostic significance of serum neuron‐specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol 43:267–270+ADs‐ discussion 270–271. [DOI] [PubMed] [Google Scholar]
  • 133. Yang K, Taft WC, Dixon CE, Yu RK, Hayes RL (1994) Endogenous phosphorylation of a 61,000 dalton hippocampal protein increases following traumatic brain injury. J Neurotrauma 11: 523–532. [DOI] [PubMed] [Google Scholar]
  • 134. Ytrebo LM, Nedredal GI, Korvald C, Holm Nielsen OJ, Ingebrigtsen T, Romner B, Aarbakke J, Revhaug A (2001) Renal elimination of protein S‐100beta in pigs with acute encephalopathy. Scand J Clin Lab Invest 61:217–225. [DOI] [PubMed] [Google Scholar]
  • 135. Zauner A, Bullock R (1995) The role of excitatory amino acids in severe brain trauma: opportunities for therapy: a review. J Neurotrauma 12:547–554. [DOI] [PubMed] [Google Scholar]
  • 136. Zemlan FP, Jauch EC, Mulchahey JJ, Gabbita SP, Rosenberg WS, Speciale SG, Zuccarello M (2002) C‐tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res 947:131–139. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES